GlassScriptPhysician profile
Naeem Z Malik
NPI 1700071487
$11,328.17
in general payments reported to CMS, 2019-2025
48 companies · $2,428 in 2025
The $2,428 reported for 2025 was more than what 79% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,084 · 2020: $723 · 2021: $485 · 2022: $2,295 · 2023: $2,588 · 2024: $1,725 · 2025: $2,428.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,379 · Education: $362.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,378.97 |
| Education | $362.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,660.88 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $1,551.46 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Jazz Pharmaceuticals INC. | $556.77 | 2019-2025 | Xywav, Xyrem |
| Mallinckrodt Hospital Products INC. | $469.48 | 2020-2025 | Acthar |
| Boehringer Ingelheim Pharmaceuticals, INC. | $387.48 | 2019-2025 | Ofev, Stiolto Respimat, Jascayd |
| Regeneron Healthcare Solutions, INC. | $383.20 | 2019-2025 | Dupixent |
| Insmed, INC. | $343.21 | 2019-2025 | Arikayce, Brinsupri |
| Genzyme Corporation | $334.33 | 2020-2025 | |
| E.R. Squibb & Sons, L.L.C. | $332.20 | 2019-2023 | Camzyos, Eliquis |
| Harmony Biosciences LLC | $325.70 | 2023-2025 | Wakix |
| Grifols USA, LLC | $268.10 | 2019-2025 | Prolastin-C Liquid |
| Philips North America LLC | $265.59 | 2019-2025 | Vest Therapy Und, (Ak6) Vest Therapy |
| Allergan, INC. | $251.87 | 2019-2020 | |
| Actelion Pharmaceuticals US, INC. | $249.28 | 2023-2025 | Uptravi, Opsumit |
| Novo Nordisk INC | $237.70 | 2022-2025 | Wegovy |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $236.81 | 2019-2024 | Xarelto |
| Pfizer INC. | $222.64 | 2019-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $211.07 | 2024-2025 | Lumryz |
| Takeda Pharmaceuticals U.S.A., INC. | $203.76 | 2022-2025 | Glassia |
| Merck Sharp & Dohme LLC | $168.27 | 2019-2024 | Zerbaxa, Dificid, Recarbrio |
| Axsome Therapeutics, INC. | $154.65 | 2023-2025 | Sunosi |
| Inspire Medical Systems, INC. | $142.09 | 2025 | Inspire |
| Teva Pharmaceuticals USA, INC. | $130.34 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $122.55 | 2023 | |
| Abbvie INC. | $117.98 | 2022 | |
| United Therapeutics Corporation | $106.78 | 2022-2024 | Tyvaso |
| Inogen, INC. | $106.66 | 2023-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Phathom Pharmaceuticals, INC. | $91.35 | 2024 | Voquezna |
| Novartis Pharmaceuticals Corporation | $61.04 | 2023-2024 | |
| Resmed Corp | $60.91 | 2021-2025 | |
| Mylan Specialty L.P. | $59.91 | 2019-2024 | Yupelri |
| Verona Pharma, INC. | $52.86 | 2025 | Ohtuvayre |
| Pulmonx Corporation | $49.00 | 2019-2024 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Zephyr Endobronchial Valve |
| Pharming Healthcare, INC. | $46.72 | 2023-2024 | Ruconest |
| Electromed, INC. | $40.07 | 2023-2025 | Smartvest |
| Baxter Healthcare | $38.19 | 2025 | Hillrom - Monarch Airway Clearance System |
| Otsuka America Pharmaceutical, INC. | $37.20 | 2019 | |
| Arbor Pharmaceuticals, INC. | $35.40 | 2019 | |
| Amgen INC. | $35.38 | 2023-2025 | Tezspire |
| Genentech USA, INC. | $28.48 | 2019 | |
| La Jolla Pharmaceutical Company | $26.21 | 2019 | |
| Circassia INC. | $21.54 | 2019 | |
| Advanced Respiratory, INC | $20.44 | 2019 | |
| Fisher & Paykel Healthcare INC | $18.95 | 2024 | Fisher & Paykel Healthcare |
| Azurity Pharmaceuticals, INC. | $17.51 | 2023 | Horizant |
| Mayne Pharma Commercial LLC | $17.08 | 2019 | |
| Shire North American Group INC | $14.96 | 2019 | |
| Viatris Specialty LLC | $14.12 | 2025 | Yupelri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Naeem Malik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.